Though this study was not powered to see the difference in clinical efficacy parameters , the patients were observed for the incidence of nonfatal MI , nonfatal stroke , re-hospitalization , death , or need for urgent revascularization due to a cardiac ischemic event at days 30 and 90 during the study .